The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials.
Where this comes from
- Record sourced from PubMed, PMID 32492144.
- Also identified by DOI 10.1093/infdis/jiaa303 and PMC identifier 7313920.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In response to provocative comments by 2 European clinicians and scientists, the World Health Organization Director General has declared that Africa will not host COVID-19 vaccine trials. Such a stance risks stigmatizing COVID-19 vaccine trials in Africa and depriving Africa of critical research. To the contrary, there is a critical need for Africa to host COVID-19 vaccine trials on public health, scientific, and ethics grounds.
Medical subject headings
- Clinical Trials as Topic
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral
- Viral Vaccines